Advancements in Lactiplantibacillus plantarum : probiotic characteristics, gene editing technologies and applications
Zhiqi Zhang,
No information about this author
Huifeng Niu,
No information about this author
Qiu Qu
No information about this author
et al.
Critical Reviews in Food Science and Nutrition,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 22
Published: Jan. 2, 2025
The
exploration
of
microorganisms
in
fermented
products
has
become
a
pivotal
area
scientific
research,
primarily
due
to
their
widespread
availability
and
profound
potential
improve
human
health.
Among
these,
Lactiplantibacillus
plantarum
(formerly
known
as
Lactobacillus
plantarum)
stands
out
versatile
lactic
acid
bacterium,
prevalent
across
diverse
ecological
niches.
Its
appeal
extends
beyond
its
well-documented
probiotic
benefits
include
the
remarkable
plasticity
genome,
which
captivated
both
industrial
stakeholders.
Despite
this
interest,
substantial
challenges
persist
fully
understanding
harnessing
L.
plantarum.
This
review
aims
illuminate
attributes
plantarum,
consolidate
current
advancements
gene
editing
technologies,
explore
multifaceted
applications
wild-type
genetically
engineered
strains.
Language: Английский
Effect of dietary anthocyanins on the risk factors related to metabolic syndrome: A systematic review and meta-analysis
Jiang Pan,
No information about this author
Jingwen Liang,
No information about this author
Z. George Xue
No information about this author
et al.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(2), P. e0315504 - e0315504
Published: Feb. 10, 2025
This
meta-analysis
aims
to
systematically
investigate
whether
dietary
anthocyanin
supplementation
can
reduce
metabolic
syndrome
(MetS)-related
risk
factors:
abdominal
obesity,
dyslipidemia
(low
high-density
lipoprotein
cholesterol
(HDL-C)
and
hypertriglyceridemia),
hypertension,
hyperglycemia
by
conducting
a
of
randomized
controlled
trials
(RCTs).
A
systematic
search
5
electronic
databases
(PubMed,
Web
Science,
Scopus,
Cochrane
Library,
Embase)
was
conducted
from
inception
until
April
25,
2024.
total
1213
studies
were
identified,
which
involving
subjects
with
MetS-related
factors,
comparing
placebo,
reporting
results
on
anthropometric,
physiological,
markers
relevant
this
study
selected.
Depending
the
heterogeneity
included
studies,
fixed-effect
model
applied
for
low
(I2
<
50%),
whereas
random-effects
employed
when
substantial
present
≥
50%).
The
weighted
mean
difference
(WMD)
95%
confidence
intervals
(CI)
calculated.
29
2006
participants.
showed
that
anthocyanins
significantly
improved
various
lipid
glycemic
markers:
HDL-C:
increased
0.05
mmol/L
(95%
CI:
0.01
0.10,
p
=
0.026),
LDL-C:
decreased
0.18
-0.28
-0.08,
0.000),
Triglycerides
(TGs):
reduced
0.11
-0.20
-0.02,
0.021),
Total
(TC):
lowered
0.34
-0.49
-0.18,
Fasting
blood
glucose
(FBG):
0.29
-0.46
-0.12,
0.001),
Glycated
hemoglobin
(HbA1c):
0.43%
-0.74
-0.13,
0.005).
Weight:
(WMD:
-0.12
kg,
-0.45
0.21,
0.473),
Body
mass
index
(BMI):
kg/m2,
-0.26
0.03,
0.12),
Overall
WC:
cm,
-0.51
0.87,
0.613),
Systolic
pressure
(SBP):
mmHg,
-1.06
0.82,
0.801),
Diastolic
(DBP):
0.61
-0.03
1.25,
0.061),
Insulin
levels:
-0.02
mU/L,
-0.44
0.40,
0.932),
HOMA-IR:
-0.11,
0.28,
0.573).
Additionally,
100
mg/day
dosage
reduced:
Waist
circumference
(WC):
0.55
cm
-1.09
-0.01,
0.047).
Subgroup
analyses
based
intervention
duration,
dosage,
health
status,
formulation,
frequency,
physical
activity
levels,
baseline
levels
corresponding
revealed
varying
significances,
particularly
in
relation
pressure.
Dietary
effectively
improve
HDL
cholesterol,
hypertriglyceridemia,
hyperglycemia,
making
them
promising
adjunct
managing
MetS.
However,
it
is
important
note
interventions
may
raise
systolic
(SBP)
diastolic
(DBP)
depending
dose,
participant
formulation.
Clinicians
should
fully
consider
these
effects
recommending
supplementation.
Further
long-term,
well-designed,
large-scale
clinical
are
needed
draw
definitive
conclusions.
Language: Английский
Eficácia terapêutica de probióticos presentes na composição do kefir em ensaios clínicos recentes
Bruna Kristyer Lima de Paula,
No information about this author
Maria de Fátima Fonseca Marques,
No information about this author
Marina Maria Barbosa de Oliveira
No information about this author
et al.
Caderno Pedagógico,
Journal Year:
2025,
Volume and Issue:
22(4), P. e14216 - e14216
Published: Feb. 18, 2025
O
kefir
é
um
consórcio
de
microrganismos,
principalmente
probióticos,
com
diversas
propriedades
terapêuticas.
Este
estudo
integrativo
analisou
ensaios
clínicos
randomizados
publicados
em
2024,
focando
na
eficácia
dos
probióticos
presentes
no
kefir.
A
pesquisa
foi
realizada
nas
bases
PubMed
(MEDELINE),
SciELO,
ScienceDirect
e
Scopus.
Os
resultados
indicaram
que
o
kefir,
devido
à
sua
diversidade
pode
proporcionar
benefícios
significativos
saúde.
Entre
os
principais
achados,
destacam-se
a
redução
triglicerídeos
pacientes
obesos,
diminuição
da
gordura
corporal,
níveis
colesterol
total,
melhora
inflamação.
Além
disso,
observada
promoção
do
aumento
biodiversidade
microbiota
intestinal,
ajudar
das
infecções
gastrointestinais
respiratórias.
Também
houve
nos
escores
depressão
síndrome
intestino
irritável.
Esses
achados
reforçam
potencial
terapêutico
destacam
necessidade
mais
pesquisas
para
consolidar
expandir
conhecimento
sobre
suas
aplicações
clínicas
Effects of Lactiplantibacillus plantarum CBT LP3 and Bifidobacterium breve CBT BR3 supplementation on weight loss and gut microbiota of overweight dogs
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Oct. 26, 2024
The
prevalence
of
obesity
in
dogs
is
increasing
worldwide.
This
study
evaluated
the
effects
a
mixed
probiotic
formula
on
weight,
body
condition
score
(BCS),
blood
metabolite
profiles,
and
gut
microbiota
overweight
obese
over
12-week
supplementation
period
to
determine
anti-obesity
Lactiplantibacillus
plantarum
CBT
LP3
Bifidobacterium
breve
BR3.
was
community-based,
randomized
that
sampled
41
with
veterinarian-determined
BCS
6
or
more.
physical
activity
all
subjects
measured
using
pedometer
designed
exclusively
for
dogs.
food
intake
developed
application.
Only
treatment
group
received
twice
daily
(3
g
per
dose).
A
significant
decrease
weight
(p
<
0.0001),
serum
TG
TC
=
0.0400),
leptin
0.0252),
significantly
increased
adiponectin
levels
0.0007)
were
observed
compared
values
control
group.
Microbiota
analysis
showed
Erysipelatoclostridium,
Staphylococcus,
Gemella
decreased
more
than
These
results
suggested
BR3
may
be
effective
alleviating
Language: Английский
Clinical Evaluation of Hovenia dulcis Extract Combinations for Effective Hangover Relief in Humans
Ki Won Lee,
No information about this author
Guangpeng Xu,
No information about this author
Dong Hyun Paik
No information about this author
et al.
Foods,
Journal Year:
2024,
Volume and Issue:
13(24), P. 4021 - 4021
Published: Dec. 12, 2024
Alcohol
consumption
is
associated
with
both
short-
and
long-term
adverse
effects,
including
hangover
symptoms.
The
objective
of
this
study
was
to
examine
the
potential
benefits
traditional
beverages
containing
a
combination
Hovenia
dulcis
extract
(HD)
either
Pueraria
lobata
(HDPB)
or
glutathione
yeast
(HDGB)
in
abbreviating
alcohol
intoxication
mitigating
A
total
25
participants
between
ages
19
40
who
had
previously
experienced
were
evaluated
randomized,
double-blind,
crossover,
placebo
(PLA)-controlled
clinical
trial.
Results
showed
that
lower
blood
concentrations
HDPB
HDGB
groups
significantly
than
PLA
group
at
0.25
0.5
h,
suggesting
HD
aids
early
metabolism
(0
p
<
0.05).
Analysis
hourly
Acute
Hangover
Scale
(AHS)
all
treatment
reduced
gastrointestinal
disorder
symptoms
compared
(p
It
can
be
confirmed
improved
by
consuming
drinks,
apart
from
effect
reducing
acetaldehyde
concentrations.
Therefore,
it
predicted
natural
phytochemicals
added
safe
for
humans
may
help
accelerate
recovery
Language: Английский
Probiotics in reducing obesity by reconfiguring the gut microbiota.
Yunuo Zhang,
No information about this author
Wei Wang
No information about this author
PubMed,
Journal Year:
2024,
Volume and Issue:
49(7), P. 1042 - 1051
Published: July 28, 2024
Obesity,
as
a
global
health
crisis,
is
increasingly
linked
to
intestinal
microecology.
Probiotics
colonise
the
body,
effectively
regulating
balance
of
flora,
while
strengthening
barrier,
activating
immune
response,
releasing
beneficial
substances,
and
maintaining
micro-ecological
balance.
This
process
not
only
enhances
defence
against
pathogens,
but
also
reduces
production
inflammatory
factors
lowers
level
chronic
inflammation.
However,
specific
mechanism
by
which
probiotics
influence
microecology
through
improve
metabolic
disorders
caused
obesity,
participate
in
weight
management
are
clear.
Through
multiple
neural
pathways
including
'gut-brain
axis'
their
direct
interaction
with
intestine,
increase
number
bacteria
intestine
inhibit
growth
harmful
bacteria,
thus
restructuring
flora.
can
optimise
environment
enhance
efficiency
food
digestion
nutrient
absorption.
show
positive
effects
on
obesity
reducing
fat
accumulation,
providing
individuals
new
way
control
body
prevent
obesity.
Therefore,
application
great
significance
promoting
gut
management.
Language: Английский